Semaglutide is a GLP-1 medication that supports appetite regulation and sustainable weight loss by reducing hunger and improving satiety. Dosing is gradual, with medication shipped directly to your door.
Tirzepatide is a dual-action GLP-1 medication that supports appetite control through two metabolic pathways. It is often selected for stronger appetite suppression and more consistent weight-loss support compared to semaglutide.
Before starting treatment, a required annual consultation is completed with a licensed medical provider. This telehealth visit ($75, once annually) allows the provider to review your health history, discuss goals, and determine if treatment is appropriate.
Based on the consultation and clinical evaluation, the provider determines eligibility and appropriate dosing. Dosing is introduced gradually to support tolerability and effectiveness, with adjustments made as needed over time.
Once approved, medication is shipped directly to your door for convenience and consistency. This eliminates pharmacy visits and insurance delays, making treatment simple, discreet, and easy to maintain.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.